Market Overview

8 Biggest Price Target Changes For Wednesday

Share:
  • Morgan Stanley raised the price target for FactSet Research Systems Inc. (NYSE: FDS) from $235 to $264. FactSet Research shares closed at $285.25 on Tuesday.
  • Stifel lowered Archer Daniels Midland Co (NYSE: ADM) price target from $56 to $51. Archer Daniels Midland shares closed at $40.42 on Tuesday.
  • JP Morgan cut the price target for FedEx Corporation (NYSE: FDX) from $184 to $172. FedEx shares closed at $155.98 on Tuesday.
  • KeyBanc lowered the price target for Micron Technology, Inc. (NASDAQ: MU) from $48 to $45. Micron shares closed at $32.68 on Tuesday.
  • Wells Fargo raised the price target on Baxter International Inc (NYSE: BAX) from $89 to $91. Baxter shares closed at $81.73 on Tuesday.
  • Bank of America cut Lennar Corporation (NYSE: LEN) price target from $57 to $55. Lennar shares closed at $48.22 on Tuesday.
  • UBS lowered the price target for Bank of New York Mellon Corp (NYSE: BK) from $49 to $45. Bank of New York Mellon shares closed at $43.43 on Tuesday.
  • Raymond James cut the price target for FedEx Corporation (NYSE: FDX) from $200 to $190. FedEx shares closed at $155.98 on Tuesday.

Posted-In: Price Target ChangesPrice Target Intraday Update Analyst Ratings

 

Related Articles (ADM + BAX)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
IQDowngrades
IQDowngrades21.0
COTYMaintains9.0
FNMaintains60.0
NNNMaintains57.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Mid-Day Market Update: Crude Oil Up 2.9%; Gemphire Therapeutics Shares Plummet

Wall Street Sees More Upside For Micron Following Earnings Pop